Zynerba Pharmaceuticals Inc (ZYNE) stock is up 18.83% today, and the average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives ZYNE stock a score of 91 out of a possible 100.
That score is chiefly influenced by a short-term technical score of 95. ZYNE’s score also includes a long-term technical score of 95. The fundamental score for ZYNE is 81. In addition to the average rating from Wall Street analysts, ZYNE stock has a mean target price of $16.30. This means analysts expect the stock to rise 111.69% over the next 12 months.
What’s Happening with ZYNE Stock Today
Zynerba Pharmaceuticals Inc (ZYNE) stock is higher by 18.75% while the S&P 500 is up 0.19% as of 2:50 PM on Wednesday, Apr 3. ZYNE is up $1.22 from the previous closing price of $6.48 on volume of 9,991,454 shares. Over the past year the S&P 500 has risen 9.88% while ZYNE is down -15.48%. ZYNE lost -$2.61 per share the over the last 12 months.